Graduate Program in Health Sciences, University of Brasília School of Health Sciences, Distrito Federal, Brazil.
J Clin Rheumatol. 2010 Oct;16(7):322-5. doi: 10.1097/RHU.0b013e3181f603bc.
Kawasaki disease (KD) is an acute systemic vasculitis of unknown etiology in which the main complication is coronary arteritis. Sensorineural hearing loss (SNHL) has also been described as a complication of this disorder. The objective of this study was to evaluate the prevalence of SNHL in patients with KD and to determine the possible causative abnormality, correlating the findings with the prevalence of cardiac complications, with the use of gammaglobulin, and with the results of laboratory tests.
A clinical cohort of 40 patients with KD seen between 2005 and 2007 was evaluated by acoustic immittance measurement and brainstem-evoked response audiometry that were performed within the first 30 days of disease and 6 months after the first evaluation. Patients with hearing disability after this period underwent further testing through otoacoustic emissions analysis. All patients were treated with intravenous administration of immunoglobulin.
Ten (25%) of the 40 patients developed coronary aneurysm, and 22 (55%) disclosed hearing loss within the first 30 days, although this problem was noticed by the parents in only 3 children. In 12 (30%), the hearing loss persisted after 6 months. Ten (83.3%) of these 12 patients also showed thrombocytosis (platelets, >500,000), 8 (66%) had anemia (hemoglobin, <10 mg/dL), and all had high erythrocyte sedimentation rate (>50 mm/hr) persisting more than 30 days.
SNHL was more prevalent than coronary complications. A significant association was found between persistent SNHL, although often not initially noted, with a prolonged presence of thrombocytosis, anemia, and high erythrocyte sedimentation rate and the delayed use of intravenous administration of immunoglobulin after the first 10 days of illness.
川崎病(KD)是一种病因不明的急性全身性脉管炎,其主要并发症是冠状动脉炎。感音神经性听力损失(SNHL)也被描述为这种疾病的并发症。本研究的目的是评估川崎病患者 SNHL 的患病率,并确定可能的致病异常,将这些发现与心脏并发症的患病率、免疫球蛋白的使用以及实验室检查结果相关联。
对 2005 年至 2007 年间就诊的 40 例川崎病患者进行了临床队列评估,通过声导抗测量和脑干诱发电位听力测试进行评估,这些测试在疾病的前 30 天内和第一次评估后 6 个月内进行。在此期间出现听力障碍的患者通过耳声发射分析进行进一步测试。所有患者均接受静脉注射免疫球蛋白治疗。
40 例患者中有 10 例(25%)发生冠状动脉瘤,22 例(55%)在最初 30 天内出现听力损失,但只有 3 例患儿的家长注意到了这个问题。12 例(30%)患者在 6 个月后听力仍未恢复。这 12 例患者中有 10 例(83.3%)血小板增多(血小板>500,000),8 例(66%)贫血(血红蛋白<10mg/dL),所有患者红细胞沉降率(ESR)均升高(>50mm/hr),持续超过 30 天。
SNHL 的发病率高于冠状动脉并发症。尽管持续性 SNHL 通常在发病后最初未被发现,但与血小板增多、贫血和高红细胞沉降率持续时间延长以及在发病后第 10 天内延迟使用静脉免疫球蛋白存在显著相关性。